What is Runway Growth's gross profit margin?

What does Runway Growth do and what are its main business segments?

What is Runway Growth's latest dividend and current dividend yield?

What is the revenue and EPS growth rate for Runway Growth year over year?

What were the key takeaways from Runway Growth's earnings call?

What factors drove the changes in Runway Growth's revenue and profit?

What is the market's earnings forecast for Runway Growth next quarter?

Did Runway Growth beat or miss consensus estimates last quarter?

- **$242M SWK Merger**: Expands healthcare/life sciences exposure to 31% of portfolio, expected to be accretive in Q1 2026.
- **Financial Performance**: Q3 net investment income $15.7M, up 13% YoY; liquidity of $371.9M supports growth.
- **Risk Management**: Portfolio risk rating 2.42, with 97% floating-rate assets and 0.2% nonaccrual loans.
- **Regulatory Delay**: Merger closing pushed to early 2026 due to SEC review delays.
- **Yield Outlook**: SWK portfolio offers higher yield, with potential for organic growth through upsizing.

**【CEO Summary Section】**
- Announced merger with SWK Holdings, adding $242 million to the portfolio and expanding healthcare/life sciences exposure to 31% of the portfolio.
- Merger expected to be accretive in the first full quarter post-closing, enhancing earnings power and diversification.
- Highlighted inorganic growth strategy through BC Partners Credit platform, with SWK as a prime example of complementary deal execution.
- Emphasized disciplined approach to portfolio optimization, including risk mitigation and monitoring.

**【CFO Financial Commentary】**
- Q3 2025 results: Total investment income $36.7M, net investment income $15.7M, up from Q2 2025.
- Weighted average portfolio risk rating increased to 2.42 (scale 1-5), loan-to-value ratio rose to 31.4%.
- Liquidity of $371.9M, with $143.7M in unfunded commitments.
- Merger with SWK expected to lower risk profile, enhance yield, and improve dividend coverage.
- Share repurchase program of $25M approved, with 397,983 shares repurchased in Q3.

**【Q&A Key Highlights】**
- **Merger Timeline**: Closing expected in early 2026, delayed by SEC regulatory review due to government shutdown.
- **Yield Profile**: SWK portfolio has slightly higher yield than Runway's, with potential for organic growth through upsizing loans.
- **Prepayment Activity**: Elevated repayments in Q3 ($199.7M), expecting normalization in Q4.
- **Competitive Dynamics**: Spread compression in venture debt, but less pronounced than broader markets.
- **Integration Plan**: SWK team to assist with transition, maintaining focus on healthcare/life sciences strategy.
- **Dividend Decision**: Q3 dividend of $0.33 covered by Q4 earnings expectations, considering prepayment income and portfolio rebuild.

Runway Growth Finance Corp. (RWAY) Q3 2025 Earnings Call Transcript

- **Q2 Financials**: NII of $13.9 million, down 11% Q/Q, driven by refinancing costs.\n- **Portfolio Growth**: $37.8 million in new investments, including first revolver structure.\n- **BC Partners Synergy**: $10 million co-investment post-quarter, expanding deal flow.\n- **Liquidity Management**: $25M share buyback program active; 1.3% NAV growth.\n- **Market Outlook**: Cautious on 2025 M&A, optimistic for 2026; 50% of unfunded commitments at risk of expiration.\n- **Risk Metrics**: 0.2% of portfolio on nonaccrual, 97% floating-rate assets.

**【CEO Summary Section】**
- Q2 2025 total investment income: $35.1 million; net investment income (NII): $13.9 million (down from $15.6 million in Q1).\n- Portfolio optimization: 3 new investments totaling $37.8 million in technology, healthcare, and consumer sectors (e.g., Autobooks, Swing Education).\n- Strategic integration with BC Partners: Access to $9 billion credit platform, enabling $20-45 million BDC check sizes and co-investments (e.g., $10 million in FHAS post-quarter).\n- Focus on 3 pillars: diversify investment sizes, expand financing solutions (e.g., revolving lines), and maximize existing commitments through risk mitigation.\n- NAV per share: $13.66 (up 1.3% Q/Q); leverage ratio: 1.05x.\n\n**【CIO Portfolio Update】**\n- Weighted average portfolio risk rating: 2.33 (stable Q/Q); loan-to-value ratio: 29.8% (up from 29.0%).\n- 97% floating-rate assets; $1.02 billion fair value portfolio (up 2.1% Q/Q).\n- Expansion into new products: revolvers (e.g., $10 million line for Swing Education), structured equity, and second lien loans.\n- Market outlook: muted M&A activity, but late-stage companies focusing on growth to attract exits; cautious on 2025 M&A, optimistic for 2026.\n\n**【CFO Financial Commentary】**\n- Operating expenses: $21.2 million (up 6.9% Q/Q) due to refinancing costs.\n- Debt portfolio yield: 15.4% (flat Q/Q, up from 15.1% YoY).\n- Share repurchase program: $25 million authorized; 815,408 shares repurchased in Q2.\n- Dividend coverage: $0.38 NII per share vs. $0.36 dividend.\n- Unfunded commitments: $164.9 million (including $35.7 million milestone-based).\n\n**【Q&A Highlights】**\n- **PIK Income**: 50% of PIK usage is strategic (e.g., winning deals), 50% defensive (supporting cash flow).\n- **Refinancing Impact**: $0.04/share Q2 cost ($0.015 one-time, $0.025 ongoing).\n- **M&A Outlook**: 2025 M&A slow due to company focus on growth; 2026 outlook brighter.\n- **Cadma JV**: Active but early; expects additional transactions in 2025.\n- **Repayment Activity**: Elevated Q3 repayments may offset interest costs, but NII could decline in Q4.\n- **Consumer Sector**: 20% of portfolio; focused on $100M+ revenue, cash-flow positive businesses.\n- **Liquidity**: $297 million available; $291 million borrowing capacity.

Runway Growth Finance Corp. (RWAY) Q2 2025 Earnings Call Transcript

- **Q1 Financial Strength**: $15.6M NII driven by $50.7M in selective loan originations.
- **Post-Merger Growth**: $30M-$150M origination pipeline with 45% BDC allocation.
- **AI Focus**: Targeting mature AI companies with proven revenue models.
- **Dividend Policy Shift**: $0.33 base dividend + 50% NII supplement; prioritizing NAV over dividend growth.
- **Risk Management**: 0.5% of portfolio on nonaccrual; 97% floating-rate loans with strong covenant protection.

**【CEO Opening Remarks】**
- Q1 2025 total investment income: $35.4M; net investment income: $15.6M.
- Completed $50.7M in funded loans across 3 existing portfolio companies.
- Post-merger with BC Partners, focusing on $30M-$150M originations with BDC allocation of $20M-$45M.
- Emphasis on credit discipline, selective portfolio expansion, and long-term risk mitigation.

**【CFO Financial Highlights】**
- Portfolio fair value: $1B (down 6.7% QoQ; -1.2% YoY).
- NAV per share: $13.48 (down 2.2% QoQ).
- Loan portfolio yield: 15.4% (Q1 2025 vs. 14.7% Q4 2024).
- Total operating expenses: $19.8M (up 3.1% QoQ).
- Prepayments: $71.9M; scheduled amortization: $3.7M.
- Liquidity: $315.4M; leverage ratio: 0.99x (vs. 1.08x Q4 2024).

**【Q&A Key Takeaways】**
1. **Healthcare Lending Slowdown**: Regulatory uncertainty and NIH/FDA cuts impacting deal flow; focus shifting to post-approval, revenue-generating businesses.
2. **Dividend Policy**: Base dividend of $0.33/share + supplemental up to 50% of NII; prioritizing NAV growth over dividend growth.
3. **AI Investment Strategy**: Targeting mature, revenue-generating AI companies (e.g., Interactions) with < $25M unfunded commitments.
4. **Portfolio Risk**: 0.5% of portfolio on nonaccrual status; weighted average risk rating: 2.33 (1=best).

Runway Growth Finance (RWAY)-12 May 25-2025 Q1 Earnings call transcript

- **Strategic Expansion**: BC Partners acquisition expands deal flow, with Q4 2024 originations of $154M in new and existing investments.
- **Financial Resilience**: NAV per share up 3% to $13.79, with 97% of loans floating-rate and earning at floors.
- **Portfolio Diversification**: Targeting $20M-$45M BDC allocations to balance risk, with 2024 venture debt growth to $53B.
- **Dividend Stability**: Base dividend cut to $0.33/share to ensure consistency amid rate volatility.
- **Market Outlook**: Slower exits but long-term venture debt growth; 88% of loans with LTV <30% support credit quality.

**【CEO Opening Remarks】**
- Q4 2024 total investment income: $33.8M; net investment income: $14.6M.
- Completed acquisition of Runway Growth Capital by BC Partners Credit, enhancing origination channels and diversifying portfolio.
- Targeting $30M-$150M total loan size, with BDC allocation of $20M-$45M to balance risk and return.
- New investments in Piano Software ($43M) and Hurricane Cleanco ($26.7M), focusing on tech, healthcare, and consumer sectors.

**【CFO Financial Highlights】**
- Portfolio fair value: $1.08B (Q3: $1.07B, YoY +5%).
- NAV per share: $13.79 (Q3: $13.39, +3%).
- 97% of loans are floating-rate, earning at or above interest rate floors.
- Prepayments: $152.6M (Q3: $75M), driven by portfolio health.
- Loan-to-value ratio: 26.6% (Q3: 29.3%).
- 2 loans on nonaccrual status (Mingle Healthcare, Snagajob), representing 0.5% of portfolio.

**【Q&A Key Takeaways】**
- **Origination Pipeline**: BC Partners' $10B+ AUM provides access to larger deals, with potential for revolvers and junior lien structures.
- **Dividend Policy**: Base dividend cut to $0.33/share to enhance sustainability; supplemental dividend up to 50% of NII surplus.
- **Market Outlook**: Slower exits and M&A activity expected to persist, but long-term venture debt growth (2024: $53B vs 2023: $27B) supports sector resilience.
- **Share Repurchases**: $25M in 2024; new plan under consideration as current plan nears expiration.

**【Risk Management】**
- Weighted average portfolio risk rating: 2.33 (1-5 scale, 1=best credit). 
- 88% of loans have LTV <30%, providing margin of safety.
- 50% of borrowers on track to meet milestones, with 91% of nonaccrual loans at fair value >90% of cost.

**【Leverage & Liquidity】**
- Leverage ratio: 1.08x (target 1.2-1.3x). 
- Available liquidity: $244.8M (cash + credit facility). 
- Unfunded commitments: $176.7M ($147.3M debt, $29.4M equity).

RWAY

RWAY fundamentals

Earnings Call

You can ask Aime